GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » Cyclically Adjusted PS Ratio

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Cyclically Adjusted PS Ratio : 1.67 (As of Jun. 16, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-16), Guizhou Bailing Group Pharmaceutical Co's current share price is ¥3.63. Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥2.17. Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 1.67.

The historical rank and industry rank for Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:002424' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.64   Med: 4.69   Max: 9.39
Current: 1.72

During the past years, Guizhou Bailing Group Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 9.39. The lowest was 1.64. And the median was 4.69.

SZSE:002424's Cyclically Adjusted PS Ratio is ranked better than
55.91% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.045 vs SZSE:002424: 1.72

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Guizhou Bailing Group Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥1.031. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥2.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Guizhou Bailing Group Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.81 4.85 4.42 4.30 3.89

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.13 4.55 3.98 3.89 3.43

Competitive Comparison of Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Guizhou Bailing Group Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.63/2.17
=1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Guizhou Bailing Group Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.031/115.2271*115.2271
=1.031

Current CPI (Mar. 2024) = 115.2271.

Guizhou Bailing Group Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.241 98.200 0.283
201409 0.076 98.900 0.089
201412 0.399 99.000 0.464
201503 0.281 99.900 0.324
201506 0.307 99.500 0.356
201509 0.328 100.500 0.376
201512 0.496 100.600 0.568
201603 0.300 102.200 0.338
201606 0.409 101.400 0.465
201609 0.358 102.400 0.403
201612 0.495 102.600 0.556
201703 0.441 103.200 0.492
201706 0.434 103.100 0.485
201709 0.335 104.100 0.371
201712 0.554 104.500 0.611
201803 0.502 105.300 0.549
201806 0.450 104.900 0.494
201809 0.513 106.600 0.555
201812 0.679 106.500 0.735
201903 0.494 107.700 0.529
201906 0.458 107.700 0.490
201909 0.510 109.800 0.535
201912 0.555 111.200 0.575
202003 0.553 112.300 0.567
202006 0.385 110.400 0.402
202009 0.561 111.700 0.579
202012 0.707 111.500 0.731
202103 0.484 112.662 0.495
202106 0.305 111.769 0.314
202109 0.526 112.215 0.540
202112 0.596 113.108 0.607
202203 0.567 114.335 0.571
202206 0.368 114.558 0.370
202209 0.539 115.339 0.538
202212 1.158 115.116 1.159
202303 0.828 115.116 0.829
202306 0.596 114.558 0.599
202309 0.591 115.339 0.590
202312 1.107 114.781 1.111
202403 1.031 115.227 1.031

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Guizhou Bailing Group Pharmaceutical Co  (SZSE:002424) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Guizhou Bailing Group Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Traded in Other Exchanges
N/A
Address
Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.
Executives
Jiang Wei Director
Jiang Yong Directors, executives
Chen Pei Directors, executives
Kuang Xun Hua Director
Niu Min Directors, Directors, and Executives
Chen Zhi Securities Affairs Representative
Zheng Rong Executives
Li Qiang Supervisors
Xia Wen Supervisors
Wang Xiao Dong Supervisors
Teng Chun Jie Supervisors
Li Hui Fang Supervisors
Zhang Jin Fen Director
Cai Shou Xian Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines